[go: up one dir, main page]

FI940167A0 - purine - Google Patents

purine

Info

Publication number
FI940167A0
FI940167A0 FI940167A FI940167A FI940167A0 FI 940167 A0 FI940167 A0 FI 940167A0 FI 940167 A FI940167 A FI 940167A FI 940167 A FI940167 A FI 940167A FI 940167 A0 FI940167 A0 FI 940167A0
Authority
FI
Finland
Prior art keywords
purine
Prior art date
Application number
FI940167A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI940167A7 (en
FI940167L (en
Inventor
Lars Jacob Stray Knutsen
Jesper Lau
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI940167A0 publication Critical patent/FI940167A0/en
Publication of FI940167A7 publication Critical patent/FI940167A7/en
Publication of FI940167L publication Critical patent/FI940167L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI940167A 1992-05-14 1993-05-12 Purine derivatives FI940167L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK92626A DK62692D0 (en) 1992-05-14 1992-05-14
PCT/DK1993/000158 WO1993023418A1 (en) 1992-05-14 1993-05-12 Purine derivatives

Publications (3)

Publication Number Publication Date
FI940167A0 true FI940167A0 (en) 1994-01-13
FI940167A7 FI940167A7 (en) 1994-03-03
FI940167L FI940167L (en) 1994-03-03

Family

ID=8095717

Family Applications (1)

Application Number Title Priority Date Filing Date
FI940167A FI940167L (en) 1992-05-14 1993-05-12 Purine derivatives

Country Status (9)

Country Link
EP (1) EP0603348A1 (en)
JP (1) JPH06508855A (en)
AU (1) AU671995B2 (en)
CA (1) CA2113547A1 (en)
DK (1) DK62692D0 (en)
FI (1) FI940167L (en)
IL (1) IL105673A (en)
NZ (1) NZ252110A (en)
WO (1) WO1993023418A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK155292D0 (en) * 1992-12-23 1992-12-23 Novo Nordisk As CHEMICAL COMPOUNDS, THEIR PREPARATION AND USE
US5589467A (en) * 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives
BR9507683A (en) * 1994-05-10 1997-09-23 Sandoz Ag Adenosine derivatives
EP0704215A3 (en) * 1994-06-02 1998-04-01 Takeda Chemical Industries, Ltd. Inhibitor of vascular permeability enhancer
GB9421133D0 (en) * 1994-10-20 1994-12-07 Glaxo Group Ltd Medicaments
US6110902A (en) * 1997-06-23 2000-08-29 Moehler; Hanns Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine
CO5180581A1 (en) * 1999-09-30 2002-07-30 Pfizer Prod Inc COMPOUNDS FOR THE TREATMENT OF THE ISCHEMIA PHARMACEUTICAL TIONS THAT CONTAIN THEM FOR THE TREATMENT OF THE ISCHEMIA
US6803457B1 (en) 1999-09-30 2004-10-12 Pfizer, Inc. Compounds for the treatment of ischemia
AU2001260076A1 (en) * 2000-05-15 2001-11-26 Novo-Nordisk A/S Compounds for treating disorders where a decreased level of plasma ffa is desired
US7414036B2 (en) 2002-01-25 2008-08-19 Muscagen Limited Compounds useful as A3 adenosine receptor agonists
US20100048501A1 (en) 2006-03-21 2010-02-25 Heinrich-Heine-Universitat Dusseldorf Phosphorylated A2A Receptor Agonists
CZ2009298A3 (en) * 2009-05-14 2010-11-24 Univerzita Palackého v Olomouci Substituted 6-benzylaminopurine ribosides, their use and pharmaceutical composition in which said compounds are comprised
EP2523669B1 (en) 2010-01-11 2016-12-07 Inotek Pharmaceuticals Corporation Combination, kit and method of reducing intraocular pressure
AU2011230618A1 (en) * 2010-03-26 2012-10-11 Inotek Pharmaceuticals Corporation Adenosine compounds and their use thereof
JP2013523739A (en) 2010-03-26 2013-06-17 イノテック ファーマシューティカルズ コーポレイション Method for reducing intraocular pressure in humans using N6-cyclopentyladenosine (CPA), CPA derivatives or prodrugs thereof
NZ627778A (en) 2012-01-26 2017-01-27 Inotek Pharmaceuticals Corp Anhydrous polymorphs of (2r,3s,4r,5r)-5-(6-(cyclopentylamino)-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)} methyl nitrate and processes of preparation thereof
BR112015021870A2 (en) 2013-03-15 2017-07-18 Inotek Pharmaceuticals Corp ophthalmic formulations
JP2015172077A (en) * 2015-06-24 2015-10-01 中国医学科学院葯物研究所 Use of N6-substituted adenosine derivatives and N6-substituted adenine derivatives for sedation, hypnosis, antidepressant, anticonvulsant, antiepileptic, antiparkinson's disease and prevention / treatment of identification
GB2582361A (en) * 2019-03-21 2020-09-23 Univ Warwick Adenosine receptor agonists

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670077C3 (en) * 1966-05-07 1975-04-24 Boehringer Mannheim Gmbh, 6800 Mannheim Adenosine derivatives and processes for their preparation
NL128629C (en) * 1966-05-07
NL6717061A (en) * 1966-12-21 1968-06-24
DE2052596A1 (en) * 1970-10-27 1972-05-04 Boehringer Mannheim Gmbh, 6800 Mannheim Novel use of N (6) -substituted adenosine derivatives
DE3406533A1 (en) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim USE OF ADENOSINE DERIVATIVES AS ANTIALLERGICA AND MEDICINAL PRODUCTS CONTAINING THEM
AU582359B2 (en) * 1984-04-18 1989-03-23 Nelson Research & Development Company N-6 substituted adenosine derivatives as cardiac vasodilators
US4791103A (en) * 1985-02-08 1988-12-13 Warner-Lambert Company 2,N6 -disubstituted adenosines, derivatives and methods of use
JPH0696534B2 (en) * 1986-04-25 1994-11-30 ヘキストジヤパン株式会社 Anti-dementia agent
GB8729994D0 (en) * 1987-12-23 1988-02-03 Glaxo Group Ltd Chemical compounds
HUT61567A (en) * 1990-12-07 1993-01-28 Sandoz Ag Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate
DK62592D0 (en) * 1992-05-14 1992-05-14 Novo Nordisk As

Also Published As

Publication number Publication date
JPH06508855A (en) 1994-10-06
WO1993023418A1 (en) 1993-11-25
FI940167A7 (en) 1994-03-03
EP0603348A1 (en) 1994-06-29
AU4061293A (en) 1993-12-13
IL105673A (en) 1998-01-04
DK62692D0 (en) 1992-05-14
IL105673A0 (en) 1993-09-22
AU671995B2 (en) 1996-09-19
NZ252110A (en) 1996-07-26
FI940167L (en) 1994-03-03
CA2113547A1 (en) 1993-11-25

Similar Documents

Publication Publication Date Title
FI940167A0 (en) purine
AT399443B (en) SPORTSHOE
FI953127A0 (en) purine derivatives
BR9305745A (en) Lightbreaker
ATA236892A (en) ROTORNUT
NO931388D0 (en) SKJOETEMUFFE
FI935044L (en) Foerbaettrad vaexelskena intended Foer vaexelsanorningtar
BR9301712A (en) APLINATOR
ATA227792A (en) SPORTSHOE
DE59301762D1 (en) Chloroethylsulfonylbenzaldehydes
NO940123D0 (en) purine derivatives
DE59206388D1 (en) Kabeleckkanal
BR7200240U (en) VARI-WATT
BR7200318U (en) HANDLEBUCKLE
ATA256392A (en) BANDROOM
ATA25994A (en) ALPINSKI
BR7201352U (en) LUNIN
BR7201859U (en) Cambao
SE9201081D0 (en) FOERPACKNINGSTRANSPORTOER
BR7202026U (en) Aero-suitcase
BR9200231A (en) AGRUPADOR
SE9200195D0 (en) KNAEVINKELFIXERING
BR9200295A (en) AURISSIMA
BR7200879U (en) COCHO SALEIRO BIAZI
FIU920532U0 (en) Bromsanordning Foer sjaelvstaengande doerrar

Legal Events

Date Code Title Description
FD Application lapsed